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To immobilize or replace a limb, custom-made medical devices must be produced by the 
orthopedic industry, such as casts, orthoses and prostheses. While very little major progress has 
been made in this area, the development of new technologies makes it now possible to produce 
immobilization devices through 3D printing that are specific to the anatomical characteristics 
of patients.  
 
This dissertation aims to determine the advantages of 3D orthoses and external prostheses, their 
barriers and limitations, as well as the feasibility of implementing the technology on the Belgian 
market.  
 
In order to test the viability of the production of 3D printed immobilization devices as an 
alternative approach, six expert interviews were conducted. The interviewees focused on main 
stakeholders: orthopedic surgeons, orthotists, 3D manufacturers and regulators. 
 
The results subsequently provided viable indications of therapeutic effectiveness and benefits 
for the patient’s quality of life. The main barriers to adoption are the economic parameter as 
well as the maturity of the technology. However, technological advances, well-defined cross-
collaboration, and an adapted business model combining a ‘SaaS’ and ‘end to end’ solution can 
overcome these barriers and ensure successful implementation. In conclusion, 3D printing 
technology in the orthopedic industry proves to have an achievable diffusion. If executed 
diligently, 3D printed orthoses and prostheses may become common devices. 
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Título: “Assistência médica encontra tecnologia: Qual é o impacto da impressão 3D em 
aparelhos imobilizadores ortopédicos” – análise da indústria 
Autor: Jade de Wasseige 
 
Para imobilizar ou substituir um membro, os aparelhos médicos feitos sob medida devem ser 
produzidos pela indústria ortopédica, como moldes, ortóteses e próteses. Embora muito pouco 
progresso tenha ocorrido na área, o desenvolvimento de novas tecnologias possibilita a 
produção de aparelhos de imobilização através da impressão 3D, específicos às características 
anatómicas dos pacientes. 
 
Esta dissertação tem como objetivo determinar as vantagens das ortóteses 3D e próteses 
externas, barreiras e limitações, bem como a viabilidade de implementar a tecnologia no 
mercado belga. 
 
Com o propósito de testar a viabilidade da produção de aparelhos de imobilização impressos 
em 3D como uma abordagem alternativa, foram realizadas sete entrevistas com especialistas. 
Os intervenientes principais foram entrevistados: cirurgiões ortopédicos, ortopedistas, 
fabricantes 3D e reguladores. 
 
Os resultados subsequentemente proporcionaram indicações viáveis da eficácia terapêutica e 
dos benefícios para a qualidade de vida do paciente. As principais barreiras à adoção são a 
vertente económica e a maturidade da tecnologia. No entanto, os avanços tecnológicos, a 
colaboração cruzada bem definida e um modelo de negócio adaptado que combina uma solução 
'SaaS' e ‘end to end’ pode superar as barreiras existentes e garantir uma implementação bem-
sucedida. Em conclusão, a tecnologia de impressão 3D na indústria ortopédica demonstra uma 
difusão viável. Se executadas diligentemente, ortóteses e próteses impressas em 3D podem se 
tornar aparelhos comuns. 
 
Palavras-chave: Impressão 3D, Aparelho de imobilização ortopédica, Nova tecnologia, 
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The additives manufacturing (AM) technology or Three Dimensional (3D) printing has 
progressively gained importance over time and developed in many economic sectors such as 
the construction, automotive, consumer goods and the healthcare industry through its variety of 
applications. (Jiang et al., 2017). Over the past 35 years, the healthcare industry has been 
benefiting from 3D printing novel technology due to its ability to create customized product of 
complex shapes with high precision (Kaye et al., 2016). 3D printing presents a great potential 
in different fields of the medical industry that need patient-specific treatment. The technology 
operates in post surgeries treatment as orthoses, implants and prostheses. AM is also used to 
prepare surgeries through anatomical modeling. It enables surgeons to gain insight into a 
patient’s specific anatomy and be better prepared for complex surgery. Moreover, AM is used 
for the customization of drugs dosage as it allows for the production of smaller quantities of 
products, which can usually not be done cost-effectively in the biomedical sector. AM can also 
produce customized drugs that require complex products in a faster and cheaper way than the 
traditional method, then make it more easily accessible to the public (Ngo et al., 2018). 
  
1.2 3D bioprinting 
 
The emergence of 3D bioprinting, which implies applications going from biomedical hearing 
aids to biomedical implants, consists of the inclusion of cells and tissues through 3D printing 
to create regenerative tissues of the human body. 3D bioprinting is one of the main drivers of 
the growth of 3D printing in the healthcare industry. In the future, 3D bioprinting aims at being 
able to regenerate tissues, skeletal structure and organs of the human body, and assure a 100% 
match transplantation when, so far, transplantations are done through donors and face risk of 
organism rejection (Milan et al., 2019). However, 3D bioprinting is challenged by the 
complexity of its technology, and research is still in its development phase. To date, although 
the technology is in a too early stage to explore its impact on medical operational performance, 





1.3 Focus of Interest 
 
The dissertation will focus on the impact of 3D printing in the orthopedic industry, i.e. orthosis 
and prosthesis, as the digital shift from “traditional technique” to 3D printing technique is 
disrupting its medical environment. This transformation implies a change in the business model, 
as well as a cultural and organizational change related to the interactions with the multiple 
stakeholders. To explore its full potential and drive better operational performance, the different 
players face the challenge of embracing the digital transformation of 3D printing in an effective 
manner (Hess et al., 2019).  
 
1.4 Problem Statement  
 
While the emergence of many new technologies has a considerable medical impact in the 
healthcare industry, the implementation of 3D printing technology must first prove its positive 
medical care for orthoses and prostheses compared to traditional technology. Then, the various 
stakeholders involved must collaborate to overcome the barriers related to cultural, 
organizational and operational changes in order to successfully commercialize 3D printed 
devices. 
 
1.5 Research Questions 
 
The analysis of the dissertation will be guided by the following research questions: 
RQ1: To what extent does 3D printing technology enhance orthopedic treatments of orthosis 
and prosthesis when compared to traditional techniques? 
RQ2: What is the potential value of applying 3D printing to these orthopedic treatments on the 
Belgian market? 




Due to the digital transformation of 3D printing technology in the medical industry, the 
following master dissertation aims at validating the impact that the technology will have on the 
orthopedic patient treatment. Current research underlines significant potentials and a strong 
awareness of the technology in this industry, as well as important barriers to make 3D printed 
orthosis and prosthesis a commonplace. The dissertation aims to reduce uncertainty about the 
mainstream diffusion of the technology and to provide an industrial outlook on the technology.  
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1.7 Scope of analysis 
 
The research of the dissertation and the industry analysis will focus on Belgium as geographical 
area. Early adopters of 3D printing technology, such as the United States, will provide guidance 
to explain some of the developments. The dissertation will be targeting every stakeholder 
involved in order to analyze the effect of the entire 3D printing technology for the orthopedic 
treatment. 
  
1.8 Dissertation Structure 
 
The following dissertation is divided into four parts that concern 3D printing technology for 
orthoses and prostheses.  
The first part reviews the literature required to provide the necessary background for the 
establishment of the research. At first, an analysis of the medical industry in terms of orthosis 
and prosthesis treatment is presented. Then, the history of 3D printing technology, and its 
important milestones, is explored, as well as a detailed explanation of the functioning of the 
technology. Additionally, the disruptive and innovative role of 3D printing technology in the 
orthosis and prosthesis industry is highlighted. Lastly, a focus on 3D printing technology in the 
orthodontic industry is used as a benchmark example. 
  
The second part of the dissertation presents the research methodology. This includes the 
collection of data from different sources, and the consolidation with existing data from the 
literature review. The objective is to establish the right methodology in order to validate the 
existing findings and bring additional information to the research. 
  
The third section provides a discussion and analysis that addresses the three research questions, 
including the advantages of the technology, its limitations, and the scenario for successful 
implementation. Additionally, the Spentys case is introduced to exemplify the role of the 3D 
manufacturer. 
 
In the fourth part, an overall conclusion is drawn from the various sections of the dissertation. 





2.  Literature Review 
 
2.1 The medical surgery industry: Orthosis and prosthesis post treatment 
 
 
The ever-increasing aging of the population has an impact on the number of disabled and 
amputee patients (Simpson et al., 2019). Proportionately, there is a growing need for orthosis 
and prosthesis devices to treat patients in the rehabilitation process (Simpson et al., 2019).  
 
2.1.1 Orthosis and prosthesis definition 
 
An orthosis is an external device (Figures 1 & 2) that supports limbs in weakened or deformed 
parts of the body for different properties: correcting and accommodating deformity; controlling 
biomechanical alignment; protecting and supporting an injury; assisting in rehabilitation; 
reducing pain; increasing mobility; and increasing independence. In order to have the best 
possible fit, and to achieve the above-mentioned goals, the orthosis is designed according to the 
shape of the body. Depending on the type of support provider, there is a wide range of 




Figure 1: Orthosis Immobilization Wrist 
 
Figure 2 : Orthosis Immobilization Ankle 
 
While an orthosis is a support device, a prosthesis is an artificial apparatus that replaces a 
missing limb. Its function is to ease the life of amputees. It implies a high degree of complexity 
because the properties of the prosthesis vary between the upper and lower limbs, while trying 
to achieve the best aesthetic appearance at the same time (Figure 3) (Georgia Tech, 2019). It 
must address stability and shock absorption for the lower limb as well as energy storage and 
return. Upper limb prostheses must be capable of grasping and reaching functionality in order 




Figure 3: Prosthesis Carbon for Lower Limb 
 
 
2.2 The 3D printing technology  
 
2.2.1 3D printing definition 
 
The 3D printing technology, also known as additive manufacturing, is “a process of creating a 
three dimensional object or rapid prototyping of 3D models from a digital file, by laying down 
successive deposits of material on top of each other as the printing machine reads data from 
the computer- aided design (CAD). Each layer is equivalent to a cross section of the CAD model 
and they fuse together to create the final shape.” (Kaye et al., 2016). 3D printing enables the 
production of prototypes, mock-ups, customized products and replacement parts by using 
different types of materials, such as resin, polymer, wax, ceramic and many more (Milan et al., 
2019). 
 
2.2.2 The evolution of 3D printing 
 
Hideo Kodama, from the Nagoya Municipal Industrial Research Institute, was the first person 
to describe the process of solid prototyping, back in 1981. His invention was the foundation of 
3D printing technology (Kaye et al., 2016). A few years later, in 1986, Charles Hull designed 
and created the first 3D printer, a process known as stereolithography (SLA). It involves a 
principle of photopolymerization to create a 3D model through a specific resin that is sensitive 
to ultraviolet, and it uses a laser to solidify the liquid resin. Subsequently, other developments 
have come to maturity such as powder bed fusion, fused deposition modeling (FDM), inkjet 
printing, contour crafting (CC) and more (Prince, 2014). 
 
Over the years, as materials and equipment of printers are developing and becoming 
increasingly sophisticated, 3D printing has been applied in various industries. Moreover, the 
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technology has become more accessible due to patents’ expiry dates. It gave the opportunity 
for innovative projects to be undertaken in different industries through the development of new 
devices, and it has enabled the use of the technology from prototypes to products (Ngo et al., 
2018). In the construction industry, for example, WinSu, a Chinese architect, printed small 200 
m2 houses entirely in 3D, in less than a day, for poor people in the Shanghai region. He was 
able to develop large-scale 3D printed surfaces that meet the requirements of industrial 
construction (Wu et al., 2016). 
 
2.2.3 Technological innovation: advantages and business model  
 
3D printing technology has specific advantages over other types of technology. It allows 
product customization and the personalization of complex shapes with high precision. It has the 
ability to produce on-site and single-use products. There is no delay between design and 
production, which allows for rapid manufacturing. Moreover, there is less waste than with other 
technologies (Kaye et al,. 2016). 
 
The technology that most closely resembles 3D printing and shares common characteristics is 
mass customization. However, they also contrast on specific points that will be analyzed in the 
next paragraph (Berman, 2012). Although firms are able to manufacture personalized products 
in small batches through mass customization, in the same way as 3D printing technology, their 
manufacturing and logistical processes differ. In terms of manufacturing technology, 3D 
printing uses raw materials based on an automated process where the product can be quickly 
designed and modified, and manufacturing can be easily outsourced. Mass customization uses 
pre-assembled components parts that must first be molded and usually require expensive tools. 
Unlike 3D printing, mass customization relies mostly on multiple suppliers due to the 
multiplicity of components, which requires a high degree of supply chain integration to ensure 
efficient logistics. 3D printing technology benefits from a small number of suppliers to readily 
purchase its raw materials and can easily switch suppliers. All this represents economic benefits, 
making the manufacturing and logistics process of 3D printing faster and cheaper than mass 
customization. Nonetheless, both types of manufacturing share similar economic advantages. 
Both do not carry finished products’ inventory because customization is done on a pre-order 
process and pre-production payment improves working capital management (Berman, 2012).  
 
 15 
Technology implies the integration of new business models due to the various changes in the 
supply chain processes mentioned above. The different advantages and variety of applications 
of 3D printing generate a real substitute for the current production process, which in turn creates 
an opportunity, but also a challenge, for established firms to undertake a new production 
process, or to reply to a new type of competitor (Jiang et al., 2017).  
 
2.3 The 3D printing applied in medical surgery: Orthosis and prosthesis post treatment 
 
The ever-evolving environment of the medical industry which is influenced by regulations, 
policies and technologies, requires healthcare providers to adapt to the environment by keeping 
patient care at the hearth of their operations (SME MMI., 2018). 3D printing technology is 
having a growing influence in the medical industry where anatomical modeling, prototyping 
and dental implants are the most popular applications. Regarding orthosis and prosthesis, it is 
facing an increasing adoption trend, with 26% of medical hubs in the US having adopted the 
use of 3D printing for these devices (Figure 4) (SME MMI., 2018).  
 
 
Figure 4: Most Popular Application of 3D printing in USA 
 
2.3.1 3D printed orthosis and prosthesis 
 
3D printed orthosis and prosthesis are based on a 4-step process to achieve the end result of 
converting a numerical model into a physical model. It starts with the acquisition of 3D images 
using computer-aided design (CAD) software. The second phase involves the processing of the 
image data, which implies image segmentation and modelization. The CAD file is converted 
into an STL file for the third phase. The STL file is then sent to the printer that uses Fused 
Deposition Modeling (FDM) technology to produce the orthosis or prosthesis. This phase also 
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includes choosing the right material for the type of the device. The final phase concerns the 
post-processing of the device through mechanical methods: sanding, abrading, vibrating and 
machining (Figure 5). The objective of post-processing is to make the orthosis or prosthesis as 
soft and comfortable as possible (Milan et al., 2019). 
 
 
Figure 5: Basic Step of 3D medical models using 3D printing and 3D bioprinting 
 
FDM technology is the method used to create the 3D printed orthosis and prosthesis, by 
depositing melted thermoplastic polymer through a filament form (Figures 6 & 7). Various 
types of materials can be used, including ABS plastics, polyamides, polycarbonates, 




Figure 6: Fused Deposition Modeling System 
 





2.3.2 The advantages and limitations compared to non 3D printed orthosis and prosthesis 
 
Over the years, the use of 3D printing technology for the production of orthosis and prosthesis 
has proven its benefits to patients. In order to analyze its effectiveness, relevant parameters 
have been studied: manufacturing time, weight of the device, fit to the body shape, and certain 
user-centered parameters such as comfort and aesthetics. The results show that its fast and high-
precision design can be easily customized and meets the requirements of custom-made orthosis 
and prosthesis. Moreover, it does not include an assembly process because of its ability to 
produce from a single piece, and then provide faster availability compared to traditional 
versions (ten Kate et al., 2017). Thanks to the freedom of design and the material used, 3D 
printing allows the creation of aerated devices that reduce skin irritation. It also makes the 
devices lighter than traditional devices. In addition, the materials used are biocompatible, 
waterproof and recyclable. These features prove the effectiveness of 3D printed orthosis and 
prosthesis compared to traditional ones, and make them more convenient to facilitate the 
patient’s daily life (Fitzpatrick et al., 2017). 
 
However, the technology also has some drawbacks to consider regarding orthosis and prosthesis. 
Firstly, orthoses printed in 3D are more valuable for secondary cast, because of the printing 
time. Secondly, there is a need to improve rapid accessibility for the initial use of the orthosis 
stabilization in case of fracture. The effectiveness of the device may also be affected by material 
shrinkage, parameters errors of the printers, CAD files or post-processing methods. Fourthly, 
the device is limited to the size of the printer, which restricts the creation of very large orthoses 
and prostheses. In addition, 3D printers can use a limited amount of material compared to 
traditional manufacturing (ten Kate et al., 2017). 
 
2.3.3 Business model evolution 
 
The digital transformation of 3D printed orthosis and prosthesis contributes to the 
transformation of the medical industry by acting on two different dimensions: process and 
product innovation, which involves an evolution of the business model (Doctors et al., 2012). 
This disrupting technology implies changes in the device itself and in the manufacturing process 




Figure 8: 3D printing Healthcare Industry Framework 
 
3D printing technology has two common types of manufacturing in the healthcare industry. The 
first one refers to a “Point-of-Care Manufacturing” (POC) or “mass customization at point of 
use”, which produces just-in-time devices at the patient’s point of care, i.e. an in-house 3D 
printing facility. The hospitals or medical hubs involved are typically larger and can afford the 
investment in equipment and personnel. The second type is “mass customization near the place 
of use”, i.e. when hospitals or medical hubs work with a traditional 3D printing manufacturer 
for production (Doctors et al., 2012).  
 
Generally, 3D printing manufacturers offer two types of solutions for orthosis and prosthesis. 
The first is an “end-to-end” solution. This type of manufacturing refers to “mass customization 
near the place of use”. It can be described in three steps: the manufacturer first provides a 
software to the orthotist for the scanning and modeling part; then, the CAD files are sent to the 
manufacturer and the modeling is reworked by developers to obtain the desired outcomes; lastly, 
the orthosis or prosthesis is printed in 3D on the manufacturer’s premises and sent to the patient 
or medical hubs. This solution is usually more valuable for complex shapes or the development 
of a new design for specific pathologies (SME MMI., 2018). 
 
The second type of solutions provided for by 3D printing manufacturer is supporting hospitals 
that have their own facility (POC) by providing a “Software as a Service” (SaaS) solution. This 
involves selling a software service for the scanning and modeling process to hospitals or 
medical hubs, and complementing POC projects with the manufacturer’s expertise. This 
solution is best suited for the production of standard models of orthoses and prostheses that 
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require a small degree of customization, such as a forearm splint in case of fracture. Both 
solutions imply a partnership between 3D printing manufacturers and medical hubs or hospitals. 
Where surgeons, orthotists and manufacturers establish a close relationship to develop patient-
specific design (SME MMI., 2018). 
 
Hospitals that set-up an in-house 3D printing facility to produce orthosis and prosthesis benefit 
from faster turnaround by eliminating shipping time. Devices can be controlled on-site, hence 
facilitating quality control and providing regulatory feedback. Moreover, POC allows for a 
combination of expertise, leading to greater interdisciplinary collaboration and better outcomes. 
This pool of knowledge and skills can lead to innovative solutions for patients and the creation 
of new types of orthosis and prosthesis for specific pathologies. It is expected that the 
manufacture of POCs will be a growing trend due to technological improvements enabling the 
easuer use of more sophisticated software and printers (SME MMI., 2018). 
 
2.4 Benchmark of 3D printing in a similar industry: the orthodontic industry 
 
In order to understand the potential value of commercializing 3D printed orthoses and 
prostheses, a benchmark comparative analysis is made with the orthodontic industry, which 
shares the common characteristics of complex custom products.  
 
The orthodontic industry has been transformed by the development of 3D printing for specific 
dental alignment uses. Orthodontic technology has been commonly used since 1999, as a result 
of Invisalign. Initially a brand name, Invisalign has also developed its own technology that 
allows the manufacture of custom-made dental appliances that are unique for each patient 
(Figure 9). Using intra-oral scanning and a computer-assisted software that creates dentition 
simulations, Invisalign produces 3D printed teething molds that are made of biocompatible 
polyurethane material, that properly realign the patient’s teeth, and that have the ability to 
handle complex cases. It offers a therapeutic treatment similar to that of traditional braces, but 
it is transparent, removable and more comfortable. It changes the patient’s smile without 
disturbing his or her life (Kaye et al., 2016).  
 
Invisalign has sold more than 4 million treatments in over 90 countries worldwide since its 
introduction on the market. It produces more than 200 000 alignment molds every day. In 
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addition, the technology is constantly improving due to significant investments in Research and 
Development that are increasing its common use by doctors (Figure 10) (Morton et al., 2017).  
 
 
Figure 9: Invisalign Dental Brace 
 
Figure 10: Growth in treatments with the Invisalign System 
 
 
This example shows that 3D printing can be successfully commercialized for the use of 
customized and complex products. Furthermore, it is now a mature technology in the 
orthodontic industry, and it proves that patient-focused innovation can overcome the barriers 
and potential resistance of traditional dental methods of alignments (Lee Ventola, 2014). 
3. Methodology 
 
3.1 Research design 
 
Despite the great opportunities for 3D printing technology, uncertainties and speculation about 
its future developments remain. The dissertation aims to answer three related fundamental 
research questions. In the literature review, it is proven that 3D printed orthosis and prosthesis 
have specific advantages over the traditional ones. Information from the literature review, 
conducted interviews, and additional reports, will be gathered to answer the first research 
question: “To what extent does 3D printing technology enhance post-surgery treatments of 
orthosis and prosthesis when compared to traditional techniques?”.  
 
3D printed orthosis and prosthesis are still in the development phase in Belgium. This means 
that the gathering of exact facts and quantitative results is still too early. Therefore, a qualitative 
approach was chosen to estimate the impact questioned in the second research question: “What 
is the potential value of applying 3D printing to these post-surgery treatments on the Belgian 
market?”. In order to answer this question, a quantitative method will be used to measure the 
value, based on qualitative components. First of all, by choosing the right parameters from the 
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interviews, literature review and additional reports, as well as their frequency. Second, the 
parameters will be assessed using a method of scaling from 1 to 5 of agreement. Additionally, 
the weight of each type of stakeholder will be established according to their importance and 
involvement in the subject. The two combined will be multiplied to visualize the outcomes. 
 
The third research question, “How can it be effectively implemented throughout this market?”, 
will be based on a Delphi method stemming from interviews with different stakeholders, as 
well as the results of the previous research questions. The Delphi method is a prediction method 
used for project management or economic prediction, based on expert interviews that are linked 
together to make a reliable future prediction (Jiang et al., 2017). The objective is to close the 
gap by predicting possible scenarios within 5 to 10 years, which assists in long-term strategic 
planning for hospitals and 3D printing manufacturers. Researchers can use this possible 
scenario as a starting point for further research on the development of the technology in the 
specific field of orthosis and prosthesis.  
 
3.2 Data collection 
 
The information that will be mentioned in the discussion part of the dissertation will draw on 
different types of data collection: interviews, literature review and additional reports. 
The data are subdivided into two classifications, primary data and secondary data.  
The primary data comes from the interviews. The objective is to interview the different 
stakeholders involved in order to have the most accurate insight possible of the topic (Table 1). 
These actors include orthopedic surgeons and orthotists, on the grounds of their medical 
expertise, as well as their knowledge and experience of 3D printing technology. They also 
include 3D printing manufacturers because they are the main players in the implementation of 
the technology. Finally, the regulators are included too, as they set the rules that cannot be 
circumvented by the technology. Most of the information will come from the primary data. 
Interviews will be semi-structured, with a certain amount of freedom to obtain spontaneous 
information from the interviewees.  





Table 1: Experts Interviews 
Interview Name Position Company/Hospital Range of revenue 
Interview A Gadhy El Koury Orthotist Institute of 
Neurosciences, 
University Hospital 
of Saint Luc 
Ø Revenue 2018: 
536 000 000 € 
Interview B David Mazy Orthopedic 
surgeons 
 
CHIREC Hospital Ø Revenue 2018: 
503 000 000 € 




of Saint Luc 
Ø Revenue 2018: 
      536 000 000 € 
Interview D Robert Elbaum Orthopedic 
surgeons, president 
of the orthopedic 
surgeons 
 
CHIREC Hospital Ø Revenue 2018: 
503 000 000 € 
Interview E Louis-Philippe 
Broze 
CEO & Co-founder Spentys Ø Fund raising 
2 650 000 
Ø Cash In 2019: 
200 000 € 
 
Interview F Non-Mentioned Representative of 
the orthopedic 
department 






4. Discussion and Analysis 
 
Before digging into the discussion part, it is necessary to clarify the types of orthopedic support 
in order to align and understand the following paragraphs. With respect to prostheses, the focus 
is on external prostheses for missing limbs (Figure 11). For the orthoses, there are two types of 
cases requiring orthopedic support. The first is for cases of injury or fracture and is referred to 
as “post-traumatic”. This is a common case in children and it involves pediatric orthopaedics. 
In this case, the immobilization of a limb is traditionally done by a cast. They are generally 
made of plaster, resin or thermoformable material (Figures 12 &13). The second case concerns 
“congenital pathologies”. A congenital disease is a pathology that affects a person from birth. 
It may be an inherited disease, although the origin of the congenital disease is not automatically 
genetic. Indeed, a congenital disease can be transmitted by one of the parents. It can also be 
contracted during pregnancy. In this case, it is a so-called acquired congenital disease 





Figure 11: Traditional Prosthesis of 
Inferior Limb 
Figure 12: Traditional Cast 
 






Figure 14: Clubfoot Pathology 
 




   
4.1 Advantages compared to traditional orthoses and prostheses 
 
The first point to consider when launching a new technology in the medical industry is the 
added value for the patient in terms of medical treatment. If this can be proven, then other 
parameters are observed to consider potential adoption of the technology. The objective of the 
following section 4.1 is to answer the first research question: “To what extent does 3D printing 
technology enhance orthopedic treatments of orthosis and prosthesis when compared to 
traditional techniques?”. 
 
4.1.1 Therapeutic impact  
  
In the case of 3D printing for the orthopedic industry, regarding “post traumatic” treatment, 
standard models of orthoses are usually required. For these standard models (see Figures 12 & 
13), studies are still at too early a stage to state that 3D printed orthoses have a better therapeutic 
added value on the patient compared to traditional orthoses. However, tests undertaken on 
patients show that patient satisfaction, comfort, and perceived function are similar, or even 
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superior, in the 3D printed orthosis (Appendix 1) under those specific conditions (Graham et 
al., 2018; Interview C). 
1. The 3D scan must be done perfectly to be sufficiently accurate. This means that no 
movement is allowed and it requires the right angle of the scanned limb.  
2. There is a prerequisite to have disciplined patients because it requires a dedication to 
wear a 3D orthosis that is not fixed. A good profile is, for example, a compliant young 
person who likes the technology and is receptive to it. A bad profile would be an elderly 
person with dementia. 
 
Regarding the use of the technology for congenital pathologies, complex cases are involved, 
such as Jaccoud’s hand or Clubfoot pathologies (Figures 16 & 17), for which the standard 
models do not match. A customized orthosis is necessary for each patient as the pathology will 
bring different types of angles and trauma to the limbs concerned. The possible customization 
through high-precision 3D printing is then necessary for complex pathologies. The 3D orthosis 
is considered to have a strong potential in this type of situation, specific to the anatomical 
characteristics of the patient (Interviews A,D,E). 
  
Figure 16: Jaccoud's Hand Pathology 
 




Even though the orthopedic industry has thought of the ideal orthosis, it was never realized. 3D 
printing technology makes it possible to approach this ideal and meet the required 
characteristics. Both the device itself and the technology have specific advantages over 
traditional devices in terms of therapeutic impact (Appendix 2). They are enumerated as follows 
(Interviews A,B,C,D). 
1. The device is more ventilated, which brings less risk of skin irritation (Appendix 3). 
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2. There is a possibility of cutaneous visibility with the feature of making openings during 
3D modeling, for example around a wound or scar, allowing daily care if it seems 
necessary (Figure 18). 
3. The 3D scanner is non-irradiating to the patient compared to the commonly used scanner, 
CT, which can develop cancer in case of high exposure. 
4. The 3D orthosis is “radiotransparent” and facilitates the examination of the patient and the 
detection of anomalies (Figure 19). 
 




Figure 18: Customized Openings for Wound or Scarce 
 
Figure 19: RX Transparency: Cast VS 3D Orthosis 
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When looking at the previous paragraph, the therapeutic aspect of 3D printing in the orthopedic 
industry has proven to be similar under specific conditions for standard models of orthoses. 
Moreover, it confirms that there are advantages to using the technology in the case of specific 
congenital pathologies requiring a high degree of customization. Finally, the device and the 
technology itself have distinct advantages that are mentioned above. Ventilation and skin 
visibility appear to be the most impactful (Table 2). It is then worth analyzing the other 
parameters of adoption in order to examine the overall added value of 3D technology for the 
different stakeholders involved. 
 
4.1.2 Social impact 
 
Once the therapeutic impact of wearing an orthosis or prosthesis is achieved, quality of life 
becomes the major selection criterion. These devices have a real impact on the patient’s social 
life. It is an uncomfortable device that interferes with daily activities such as showering, writing, 
cooking, etc. Overall, children are the main customers for orthoses and casts, and 3D printed 
orthoses will give them the opportunity to live more easily. Additionally, the social aspect is 
linked to the therapeutic aspect since the comfort of the device will have an impact on the 
resilience of the treatment. If the patient does not approve of the orthosis, or if it is too 
uncomfortable, it is more likely that the patient will not wear it as he should do, and will then 
lose the therapeutic effectiveness of the treatment. The major quality of life impacts of a 3D 
orthosis compared to a traditional orthosis are as follows (Graham et al., 2018; Interviews 
B,C,D,E). 
1. The weight of the 3D orthosis and prosthesis is lower, and therefore more comfortable 
to wear. 
2. The 3D orthosis is more ventilated and allows the skin to breathe more easily, which 
reduces odor due to less confinement.  
3. The 3D orthopedic supports are waterproof, which eases patients’ life and enables them 
to enjoy certain pleasures, such as taking a proper shower, cooking or swimming, which 
would not be possible with a traditional orthosis or cast for example.  
4. It is recyclable. At the end of the treatment, the orthosis must be returned to recycle it 
and reduce plastic waste without compromising patient care. Furthermore, it is in line 
with the values of the current generation with regards to the issue of waste.  
5. The many possibilities for customization also improve the aesthetics of the device 
thanks to its organic shape that reduces barriers to wearing it.  
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4.1.3 Disadvantages and improvements 
 
In the following paragraph, the three main limitations of the technology for orthopedic 
immobilization devices will be mentioned. 3D printing technology for orthopedic supports is 
in a transitional phase on the Belgian market. It has already been seen above that it brings many 
advantages in the treatment of patients. Nevertheless, the technology still needs some 
improvements in order to be commercialized. These improvements are now considered to be 
disadvantages compared to traditional methods. The first and most important one is the printing 
time (Table 4): it takes too much time to produce an instantaneous device, which is a necessity 
in some medical cases such as fractures. Moreover, the technology must save time for the 
orthopedic surgeon and orthotist, otherwise they will reduce their work efficiency and have a 
negative impact on the patient’s treatment. Looking at the table 4, it is seen in the third column 




Table 4: Time Production Comparison of the Different Types of Forearm Orthoses  
 
 
The second disadvantage is the printing failure that can occur and which then requires the 
device to be reprinted. This results in a waste of material and time. Lastly, the software for the 
scanning and modeling process still needs some improvements. The reliability of the scan is 
not 100% guaranteed, it may lack precision, which can cause design errors and, in some cases, 
be harmful to the patient (Interviews A,C). 
 
Table 5: Quantitative Analysis of the Disadvantages of the 3D Technology 
 
 
The ability to overcome these barriers will be critical to the potential commercialization of 3D 
printed orthosis and prosthesis. In the meantime, it is anticipated that technological advances 
will allow for a significant reduction in printing time in the near future, as well as continuous 
software improvements (Interviews A,B,C,E). 
 
To summarize part 4.1 of the dissertation and answer the first research question “To what extent 
does 3D printing technology enhance orthopedic treatments of orthosis and prosthesis when 
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compared to traditional techniques?”, it appears that the therapeutic aspect and social aspects 
are interlinked. However, the therapeutic benefits come first in order to analyze whether the 
adoption of the technology is worthwhile. It appears that the most important therapeutic 
advantage is visibility of the skin, followed by ventilation. In terms of social impact, weight 
and odor are the most influential with regards to adoption. Lastly, the most critical disadvantage 
is production time (Table 6). 
 




4.2 Potential Value of Applying 3D Printing 
 
 
The objective of the following section 4.2 is to answer the second research question: “What is 
the potential value of applying 3D printing to these orthopedic treatments on the Belgian 
market?”. Before assessing the potential value of diffusion, different aspects must be 
understood, including some background information about the organizational structure and the 
people involved in the orthopedic devices process. The digital enablers of the digital 




4.2.1 Background information 
 
The process of delivering an orthosis or prosthesis in Belgium will be explained in the following 
paragraph in order to understand the cross collaboration, the current business model and the 
organizational aspect of traditional orthopedic supports. 
First of all, when a patient requires an orthosis or prosthesis, he or she must be examined by an 
orthopedic surgeon. The surgeon examines the injured or missing limb and, using his or her 
expertise, decides whether an orthosis or prosthesis is needed. If so, the surgeon prescribes the 
necessary device and the prescription is given to the orthotist who is responsible for the 
production of the device, the setting-up, and the follow-up of the patient. The people involved 
in the process are thus the orthopedic surgeons, the orthotist and the patient (Interviews B,D). 
 
In terms of costs and prices, in Belgium, the prices of devices are set by the INAMI and are 
referring to codes (National Institute of Health and Disability Insurance) (Appendix 4; 
Interview F). The codes are 100% reimbursed by the patient’s health insurance. In Belgium, it 
is compulsory for every citizen to subscribe to a health insurance. The totality of the 
reimbursement goes to the orthotist. In some cases, the orthotist may also overcharge a user fee 
of maximum 10% of the INAMI code that has to be paid by the patient and which is not 
reimbursed (Interviews B,D,E).  
 
4.2.2 Digital enablers 
 
The implementation of a new technology in any industry implies changes where certain 
parameters must be adapted or must adapt themselves to this new technology. The successful 
implementation of 3D printing technology in the orthopedic industry will depend on the ability 
of digital enablers to alleviate barriers to adoption. The greatest challenge is usually the 
willingness to adopt the technology, and not the technology itself.  
In Belgium, the digital enablers involved in the implementation of 3D printing in the orthopedic 
industry are list below. 
Firstly, 3D printing manufacturers have a major role to play in convincing and educating 
surgeons and orthotists to adopt the technology and smoothly implement a new type of 
production. Cultural and organizational change is needed to successfully support the technology, 
where those involved must be receptive to 3D printing and open to working through a digital 
process. Moreover, the ecosystem of partners is changing with the arrival of new 3D printing 
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manufacturers and brings about modifications in terms of cross collaboration between the 
surgeon, the orthotist and the 3D manufacturer. 
Secondly, in order to be successfully adopted, the incentives of the new technology must 
outweigh the ones of traditional orthoses and prostheses, medically speaking, but also in terms 
of time and cost for the orthotist and the surgeon. 
Thirdly, the technology must be mature and precise enough to be widely used by the medical 
core and commercialized. Moreover, IT support and technical maintenance must be available 
in case of printer or software malfunction. 
Fourthly, in order to comply with national rules on the pricing and reimbursement systems of 
orthosis and prosthesis, regulators must adapt it to 3D printing, which is not yet the case, due 
to the early phase of implementation. 
 
4.2.3 3D Printing Manufacturer: Spentys Case 
 
 
As previously seen, 3D printing manufacturers play a major role in the diffusion of the 
technology. To illustrate this role, the example of the stakeholder Spentys will be presented. It 
is a Belgian start-up, created in 2017, which produces 3D printed orthopedic immobilization 
devices. Their mission is to bring the value of mass customization to the orthopedic 
environment. They have developed a 3-step solution centralized in a software package: 3D 
scanning, 3D modeling and 3D printing (Appendix 5). Their current business model is based 
on an “end to end” solution. For the first step, they educate orthotists to use their 3D scanning 
in the hospital (Appendix 6). The scan is sent directly to the Spentys team, which takes care of 
the 3D modeling and printing. Spentys is in an early stage of commercialization, they are doing 
numerous tests in collaboration with orthotists and orthopedic surgeons to obtain approval of 
the technology from a medical care point of view (Interview E). 
 
The choice of Spentys to represent a manufacturer of 3D orthopedic devices in this dissertation 
was made carefully by looking at the competition. Spentys’ main competitors in Belgium are 
Materialise and Twikit (Appendix 7). Materialise is active in many industries, including the 
healthcare sector. They specialize in anatomical modeling for surgical preparation. This enables 
surgeons to gain insight and time for a specific surgery, which is valuable for both the patient 
and the surgeon (Materialise, 2019). Twikit mainly operates in two different industries: the 
automotive industry and the healthcare industry. As Spentys, they also focus their business 
model on orthosis and prosthesis. However, they only cover the 3D software aspect; they do 
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not offer a 3D scanning and printing solution. This means that they do not collaborate with the 
medical core to develop a specific design, but let them do it by themselves (Twikit, 2019). 
 
Spentys is the only firm in Belgium to focus its core business on 3D printed orthosis and 
prosthesis, and to cover a solution for the whole value chain of the device. Moreover, it aims to 
commercialize it in hospitals and to develop a specific design that does not yet exist (Appendix 
8). On the one hand, their goal is to combine this new technology with traditional techniques 
that are complementary to each other. On the other hand, they intend to replace old-fashioned 
techniques where 3D brings advantages to the devices (Appendices 9 & 10; Interview E). 
 
These 3D manufacturers are disrupting the established organizational process. By entering the 
loop, they are asking orthotists to change the way they work. First of all, the orthotist must use 
a 3D scan and be trained to do so. Second, with the “end to end” business model, the orthotist 
is no longer responsible for the production of the device. Economically speaking, the 
reimbursement of the device by the health insurance is then divided, since the production and 
the laying of the splint is done by two different entities, namely the 3D manufacturers and the 
orthotist (Interviews D,E). The major problem that Spentys faces is that the orthotist is used to 
get full reimbursement with the traditional technique because he also takes care of the 
production. Therefore, Spentys has to find a way to convince and prove that it is economically 
advantageous for the orthotist to use 3D printing technology, which is not the case with their 
“end to end” solution. As mentioned earlier, the economic factor is a major parameter of 
adoption (Interview B). In order to do this, Spentys plans to adapt its business model and add a 
“SaaS” option by January 2020 (Interview E). 
 
4.2.4 Assessing the value of implementation  
 
Once the organizational structure of orthopedic immobilization devices is understood, as well 
as how the sector is being disrupted by the arrival of 3D manufacturers, it is necessary to discern 
the willingness to adopt by the different stakeholders involved. A frequency analysis was 
created by translating the qualitative components into quantitative data to assess the value of 
the technology and its diffusion. All respondents were asked to respond to their level of 
agreement on a scale from 1 to 5 with respect to the five main potential barriers to large-scale 
diffusion of the technology. These barriers were based on 5 criteria for adoption: uncertainty, 
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complexity, economic importance, novelty, and the need of the technology for orthopedic 
supports. They are listed as follows. 
1. Lack of regulation of the 3D production process for orthopedic supports 
2. Lack of knowledge and skills in 3D printing and its software for the production of 
orthopedic supports 
3. Uncertainties about the required investment and economic return  
4. Uncertainties about the maturity of the technology (performance of the material and 
available hardware)  
5. Uncertainties about the need of the technology for orthopedic supports 
The weight of importance from the stakeholder groups towards the diffusion of the technology 
have been decided as follow. In this early phase of implementation, orthopedic surgeons have 
an important decisional power. As they are the first medical core involved in the treatment of a 
patient, if they are favorable to the 3D printing technology, they are likely to send their patients 
to orthotists using the technology. Then the orthopedic surgeons have a strong negotiation 
power over the orthotists the adopt the 3D technology if those ones want to keep their 
collaboration with the surgeons. In this reason, the weight of importance for the implementation 








As can be seen from the analysis in Table 7, uncertainty about the need of the technology for 
orthopedic supports is the least critical barrier with a 1.7 degree of importance. This means that 
all four types of experts involved are assessing the medical care potential of 3D orthopedic 
supports. 
 
The lack of regulation is also not considered a significant barrier to adoption with a degree of 
importance of 2.2, as it the second least important one. The diffusion of the technology is still 
in the development phase, but it appears that the INAMI is willing to cooperate and create 
pricing codes for 3D orthopedic supports if the technology can prove its therapeutic impact. 
Nonetheless, it turns out that the appropriate pricing codes will be set once the technology is 
widely disseminated. Otherwise, the INAMI does not consider this new pricing code to be 
necessary (Interview E). 
 
The main stakeholders involved in the production of orthopedic supports are orthotists and 3D 
manufacturers. Both categories fall between low and moderate in terms of the lack of 
knowledge and skills of 3D printers and the required software. This shows that the complexity 
of the technology is not recognized as an important fear of adoption with a 2.2 degree of 
importance. 
 
Nevertheless, while it seems possible to overcome three of the barriers, two critical criteria 
remain constraints to widespread diffusion: the economic aspect and the maturity of the 
technology.  
 
Starting with the economic impact. With a degree of importance of 2.6 of uncertainties towards 
the investment required and the economic returns, it is a high barrier of adoption. 
As the technology is still in an early phase of diffusion for orthopedic immobilization supports, 
there is not yet evidence of economic return. Moreover, it has been seen that the business model 
of 3D manufacturers refers to an “end to end” solution which includes an economic 
disadvantage for the orthotists. This means that with the current “end to end” situation there is 
no incentives for the orthotist to jump in the 3D printing business industry for orthopedic 




The last criteria to take into consideration is maturity of the technology. With a degree of 
importance of 2.8, the fact that the technology is not mature enough can have direct deleterious 
effect on the patient. Therefore, it is logical that the medical core, orthopedic surgeons and 
orthotists, consider this criterion as a significant barrier to adoption. However, technological 
progress will greatly reduce this uncertainty. Thanks to intense collaboration between engineers, 
3D manufacturers and the medical core, printers and software will continue to improve in terms 
of production time, accuracy and product quality, all of which are now considered as 
disadvantages (Interviews A,B,C,E). By delivering a drastic technological evolution, the degree 
of agreement is likely to switch in the opposite direction. To give an example of advanced 
technology for production time criteria, 3D manufacturers are testing the production of 3D cast 
made of resin in less than 2 hours (Appendix 11). If these casts are medically certified, this will 
have a considerable impact on the expansion of the technology in the orthopedic immobilization 
supports industry. The focus on casts in the pediatric department is a wise choice. Children have 
grown up in an environment that is more prone to injury or fracture. These small fractures are 
the most common ones that require a cast. It thus represents a huge market for the 3D printing 
industry (Interview E). 
 
As discussed throughout section 4.4.4, the assessed value for large-scale diffusion of 3D 
printing technology for orthopedic supports is promising, despite some critical and some less 
significant barriers still to be overcome. However, all of them are taken into consideration by 
the 3D manufacturer.  
 
4.3 Successful implementation  
 
On the basis of the primary and secondary data collected in the dissertation, a possible scenario 
is created to answer the third research question: “How can it be effectively implemented 
throughout this market?”. This is done by focusing on the business model, the collaboration 
between the main stakeholders and the opportunities of the technology.  
 
4.3.2 Full package solution 
 
Once comfort and therapeutic effects have been proven, it is necessary to review the financial 
strategy. As the technology is still at an early stage of commercialization, it cannot yet prove 
its economic viability with real figures. Hence, a financial hypothesis is made that, if it can be 
demonstrated, there is a real potential for 3D orthopedic devices to be commonly used. 
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The hypothesis is: “By providing a full package solution with “end to end” and “SaaS”, the 3D 
manufacturer covers the entire value chain of orthopedic immobilization devices and is 
financially advantageous for orthotists and 3D manufacturers.” 
 
In order to respond to the above hypothesis, 3D manufacturers must adapt their business model 
by introducing a “SaaS” (Software as a Service) solution, in addition to the “end to end” 
solution. The two business models will have different purposes. The “end to end” is necessary 
for complex cases of congenital pathologies, where an important customization of the device is 
required. The reason behind this is that collaboration between orthopedic surgeons, the orthotist 
and the 3D manufacturer is necessary for the design of complex shapes. In this case, the pricing 
strategy does not change, and reimbursement is shared between the 3D manufacturer who 
produces the device and the orthotist (Interview E). This business model is an effective 
approach to convince the medical core of the technology and gain visibility before introducing 
the SaaS model. It links the medical and emotional aspects to treat complicated pathologies, 
which is an incentive for them to use it (Interview E). However, the 3D printing manufacturer 
cannot stay alive solely by modeling and producing  devices for complex cases. The number of 
these specific cases is too small for an entire business to rely on this model. From an economic 
point of view, it is not viable (Interview C). 
 
The second business model, “SaaS”, will involve the production of orthopedic immobilization 
devices at the place of use (with reference to the literature review: POC manufacturing). The 
SaaS will focus on standard model devices requiring a small amount of customization, primarily 
for post-traumatic treatments. In order for 3D manufacturers to implement the SaaS strategy, 
hospitals or orthotists hubs must have an in-house 3D printer. To overcome the high investment 
hurdle for hospitals or the orthotist department in purchasing 3D printers, the 3D manufacturer 
can offer a package that includes the rental of 3D printers. This will change the pricing strategy 
from the “end to end” solution. Since production will take place at the point of care (the hospital 
or orthotist hub), the full reimbursement goes to the orthotist, which is similar to the pricing 
strategy of traditional methods. In return, the orthotist hub will pay a monthly fixed fee to the 
3D manufacturer for the “SaaS”, the rental of 3D printers, the educational tool for proper use 
of the technology and the maintenance service. Additionally, the hub will pay a variable fee to 
the 3D manufacturer based on the number of orthoses made per month (Interview E). 
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By providing a full package solution with the “end to end” and the “SaaS”, the 3D manufacturer 
covers both types of orthoses mentioned in this dissertation, i.e. the complex ones that require 
a high degree of customization, and the standard ones that can be customized in mass. Moreover, 
with the “end to end” solution, the manufacturer is also able to produce individual external 
prostheses (Figure 20). If 3D manufacturers are able to successfully introduce the “SaaS” 
strategy, they will fulfill their mission to bring the value of mass customization to the orthopedic 
environment. 
 
Figure 20: External Forarm Prosthesis by Spentys 
 
 
4.3.2 Cross Collaboration 
 
The entry of the 3D manufacturer, a new stakeholder in the orthopedic immobilization industry, 
is not without its challenges. It disrupts the way orthotists operate, which generates resistance 
to change. However, there was unanimous agreement among those interviewed that, culturally 
speaking, the adoption of this new technology is only a matter of time or generational change 
(Interviews A,B,C,D). 
 
The key to a successful implementation involves smooth cross collaboration between the 3D 
manufacturer, the orthotist and the orthopedic surgeon. In order for them to work in synergy, 
the medical core must clearly understand the benefits of adopting the technology.  
 
First of all, the introduction of a “SaaS” business model implies that orthotists have their own 
3D printer facilities. It does not apply to orthopedic surgeons. Even if they have the expertise, 
they prefer to work in collaboration with the orthotists, as it would otherwise require additional 
work. They do not have the time to produce 3D orthopedic devices in-house. This means that 
there is no conflict of interest with those who adopt the technology (Interview C,D). 
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The “end to end” and “SaaS” package solution enables 3D manufacturers to cover the entire 
value chain of orthopedic immobilization devices and ensures economic added value for the 
orthotist. For the orthotist, as no physical individual is required to produce the device, it saves 
time and operational flexibility (Table 4; Interview E). By adopting this technology, orthotists 
are increasing their margins on the long term. The technology lowers the production costs once 
the initial investment costs have been recovered. Moreover, the fixed costs of salaries are 
decreasing due to a greater operational flexibility and a smaller amount of physical orthotists. 
(Interview E) 
 
4.3.3 The Technology as an Opportunity 
 
The diffusion of a new technology in an industry has an intriguing and exciting aspect. This is 
the reason why the storytelling around the new technology is a powerful tool for persuasion. 
The 3D manufacturer can play on the innovation factor that is directly linked to the reputation 
of a hospital or an orthotist hub. If hospitals have an in-house facility and produce 3D printed 
devices, it is a favorable tool of persuasion to attract new patients, as new technologies attract 
the new generation of patients (Interview B). 
 
The storytelling can also revolve around the green trend. With the new generation’s growing 
awareness of environmental issues, the recyclability factor of 3D printed orthopedic devices is 
a powerful tool for persuasion. Manufacturers can play on this added value: the product is even 
more attractive if it is recyclable (Interviews B,E). 
 
Another type of opportunity is to use other aspects of 3D printing technology to create 
advantages. The material itself can be used as a force for the comfort and therapeutic impact of 
the patient. Firstly, 3D printers allow the materials to be mixed; bi or tri materials can be 
blended together to create articulated orthoses. This pluri-material technique makes it possible 
to combine flexible parts of the device with other parts requiring total immobility. This 
characteristic has a direct therapeutic impact.  
 
Secondly, 3D printers can be used to create devices made of resorbable material (PVA filament) 
that can be useful for orthopedic devices. It can be used in two types of cases. In the first case, 
the patient removes the orthosis by himself by immersing it in water when the treatment is done. 
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This facilitates the organizational process and does not require the patient to return to the 
hospital to remove the orthosis. Resorbable devices for this type of case are not yet operational, 
but are being considered for future improvement (Interview C). In the second case, 3D printers 
can make the scaffolding of the 3D product resorbable, which requires the 3D product to be 
immersed in water after printing to remove the scaffolding by itself. This feature makes the 
production process easier and saves time. As technology continues to advance, 3D 
manufacturers will add new attributes to orthopedic devices that will give them more and more 
bargaining power to sell them (Interview C). 
 
A foreseeable scenario within the next five years would be to implement a full package offer 
containing an “end to end” and “SaaS” solution in order to cover all types of orthoses and 
external prostheses. Moreover, the 3D manufacturer, the orthotist and the orthopedic surgeon 
must work in synergy and the benefits of adoption for all three players must be well defined 
and understood. Finally, the technology itself must be used as an implementation opportunity 
because of its constant technological advances. The storytelling around the trend of innovation 
must be played out and the technical aspects of the technology must be used to make it an 
advantage. That is, the specific use of materials or structural possibilities during the modeling 
phase to gain flexibility (figure 21). 
 
 











This dissertation endeavored to present the advantages of 3D printed orthopedic immobilization 
devices, their limitations and their opportunity for implementation on the Belgian market. 
The biggest challenge of this technology is to enter an already well-established and well-
functioning industry. The evolution of 3D technology in the orthopedic industry can be 
compared to the diffusion of the LED lamp. Initially, no one believed that the LED lamp could 
replace Thomas Edison's light bulb, since the bulb was lightening perfectly and there was no 
reason to switch to another technique. However, it was then realized that the LED could have 
the same light intensity as the light bulb while saving energy and being economically 
advantageous (Interview C). 
 
First of all, concrete clinical studies are underway to prove the non-inferiority of 3D printed 
devices compared to traditional orthoses and prostheses. In the long term, given the 
technological advancements, the objective is to prove therapeutic superiority. Nonetheless, it 
has been found that the social life of the patient is positively impacted by the technology. It 
enhances comfort and facilitates daily tasks compared to traditional orthoses, which is directly 
related to the therapeutic effectiveness of the technology. 
Secondly, for a successful implementation, the most suitable business model for the 3D 
manufacturer is the combination of an “end to end” and a “SaaS” solution, moving from a 
product-based logic to a service logic for standard models that require a small customization. 
This business model has an economic added value for the 3D manufacturer, as well as for the 
orthotist, and meets the technology's mission of mass customization. 
By demonstrating that the technology is not medically deleterious for the patient and that, 
financially speaking, it is advantageous compared to traditional orthoses and prostheses for the 
main stakeholders involved, it will then likely take a prominent place in the orthopedic market. 
 
Although the technology may still be flawed in terms of production time and reliability of 
scanning, researchers are constantly improving the performance of printers, materials and 
software, which ensures medical advances and successful implementation of the 
technology. Further industrial collaboration, additional clinical studies, and regulatory 





The research is not without its limitations. Whilst the quantitative analysis provided key insights, 
the fact that these figures are derived from the translation of qualitative components remains a 
weakness in the analysis that was subsequently carried out. The inclusion of additional 
statistical data could have improved the accuracy of the research. 
 
Furthermore, the early phase of implementation of 3D technology on the orthopaedic market in 
Belgium is not yet generating economic results. The dissertation mainly based its results 
hypothesis on the lessons and insights learned from the interviews to analyse the financial 
benefits. 
 
Although scientific studies are still underway to prove the therapeutic effectiveness of the 
technology for orthopaedic immobilization devices, access was not available to all of these 
studies. This could have been more useful and accurate for this particular point. 
 
Further research should be undertaken to gain deeper insights and more accurate information 
in economic and therapeutic terms. However, the objective of this dissertation was to provide 
a general overview of the implementation of 3D technology for orthopaedic immobilization 
devices, including the advantages and the most suitable business model.  
 
Despite the limitations, it is hoped that this dissertation will inspire further studies on this 
inspiring topic that can affect us all. 
 
5.3 Final notes 
 
“With 3D printing, we can actually create structures that are more intricate than any other 
manufacturing technology – or, in fact are impossible to build in any other way.” 
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A. Orthotist Gadhy El Koury - Institute of Neurosciences, University Hospital of Saint Luc – Brussels, 
Belgium (30/10/2019) 
Focussing on external orthoses and prostheses. The question is, in Belgium, how is the situation and 
how can it be on long term. 
Ghady: 
Must be careful when mention that 3D printed orthoses and prostheses have an added value on the 
patient. à Define clearly the parameters because medically speaking, it is not proven that 3D printed 
orthoses repair better injuries than traditional ones because no proper evaluations.  
Subjective from the patient and depends of the injuries from the surgeons. 
 
Medical parameters and gadget effect 
Parameters evaluated so far: comfort, aesthetics has advantages over traditional ones. 
If it is well scanned and molded, it has then an advantage looking on a social aspect, however still 
struggling on a 100% clear scan.  
The gadget effect, tell a story (of 3D) appealing for choosing the 3D. 
Medically speaking: 3D for complex cases is very useful, when standard sizes don’t match à 3D is 
necessary in this case. Customization of specific pathologies 
The gadget effect: For the standard size à not medically necessary because the difference is minimal 
or non, comparing to traditional ones. To sell in this category: play around the story of 3D printing. 
3D materials better or not? Polypropylene and thermoformable: same feelings of plastic on the skin, 
biocompatible. So yes because more comfort, less irritation, less smell, less roteness. 
Tech mature enough to commercialize it? The orthoses are not mature enough regarding the flexibility 
of the materials, scan has still too many errors, adv of not being irradiant but then not 100% exact. 
 
Dc.Ghady own opinion regarding tech: Favorable to explorate what can be beneficial for the patient. 
Parameters to check: added value for the patient and added value for the surgeons in terms of time, space 
and money for society and hospital (cost reduction and time reduction, gain space). 
3D printing we can still not say if these parameters are applicable for the surgeons because the time to 
print is still too long but believe that the future technological advance of 3D printing will dramatically 
reduce the time of production. 
 
End to end solution and SaaS: Clearly it is better to produce internally at the hospital because no need 
to anticipate, can be print on the moment. à The scan is done directly of the right limb. Less 
inconvenient for the patient, no need for displacement (back and forth) of the patient to pick the orthoses 
or prostheses as it is done directly.  
In Belgium, no internal 3D production in hospital so far. 
 
Economic: so far, the surgeons do not pay for the orthoses, the patient does and gets refund. The question 
is who get the surplus? Example for a 3D printed orthosis: an orthosis for the hand cost 15€ to produce, 
sell it at 80€ (price set by INAMI), the manufacturer gets the entire surplus. 
However, if it is internally done, then the surplus would go for the surgeons/hospitals. (They must be 
convinced that they will earn more than it costs. 
Economically speaking for surgeons: hard to predict now that they earn more money than trad ones. 
However, the internal infr. Could give them an opportunity to earn more. (interesting in the negotiation, 
proof the surgeons that they will earn more money) 
 
Cultural change: three types: 
1) We have always done like this why should we change (old generation) 
2) Nice a new product we have to adopt 
3) Middle attitude, wait to see how it goes on the market (Better suits for surgeons which 
first criteria: comfort of the surgeons economically speaking but also time reduction) 
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Bandagistes are important for the after-sale services 
Barriers: the change most important one, changing his habits is complicated, (it’s like asking someone 
to stop drinking coffee). If it’s proven that it has adv. It just takes time to adopt it. Sometimes it is not 
only time but a real change of generation to adopt a new tech 
Internal infrastructure: who decide? Orthopedic service  
Communication between the surgeons: cost X, gain Y. However too few discussions and unilateral. 
Discuss together and analyze the receptivity. Not mandatory that every surgeon uses 3D printing that’s 
why it’s important to check the receptivity of everyone before installation of internal 3D printing facility. 
In order to make the printer profitable need a certain amount of surgeons receptive to use it. 
The role of the manufacturer à Internal infra: proof that is profitable. 1st parameter is money. 
Manufacturer as Spentys has a great role to play to convince hospital to go internally because for them 
the SaaS service is more profitable on the long term. 
Future scenario: 







































B. Doctor David Mazy – Orthopedic surgeon at CHIREC Hospital- Brussels, Belgium (10/11/2019) 
 
Barriers and limitations 
Time of the production à however it is obvious that it will be shortened with the technological advance 
in the near future. 
Finance: not the biggest problem to overcome, at some point it will be realized that will earn more than 
it cost 
Intermediary:  need less intermediaries, organizational barrier 
à Once these three barriers have been overcome, easily to commercialize  
 
Advantages and Opportunities 
3D printing is future in the medical industry at every level  
Must be proven that the therapeutic efficacy is as good as the traditional splints then look at the quality 
of life to check if the impact on the patient is the same. 
Expertise of Dc Mazy: same results for the wound but in the case of disciplined patient because asks 
dedication. 
Good profile: receptive young people who like the tech aspect 
Social aspect: wearing a plaster has real impact on the social life and the 3D printed splints and orthoses 
give the opportunity to live more easily. Major impact on quality of life: less heavy, more aerated, don’t 
smell, go into the water, cook 
Storytelling around the innovation aspect: new tech attract new patient generation. It a hospital use it, it 
must be said  
Recyclable (40% of the product): People will bring back their orthosis if they know about the fact that 
is recyclable, if awareness has been raised à again storytelling around this, it is a trend: the green trend, 
eco trend. Positive point, even more attractive when you know it is recyclable 
Use different type of materials: specific percentage of materials to give more flexibility 
The plaster will always stay in immediate post trauma but will be combine with the 3D orthoses/splints 
 
Be careful to not look only at the cost because other important parameters: 
Product itself better for the quality of life of the patient  
Trendy effect  
Give a new and exclusive image for the hospitals  
 
Economically speaking 
Surgeons thinks first what’s best for the patient (should always be the priority), however will use it if 
economically benefiting for them. 
 
SaaS & End to End solution 
Less intermediary, less costà having its own internal facility in hospitals, better for the hospitals. Printer 
at consultation point, no need for intermediaries. The revenue goes to the hospitals/surgeons. 
If it is proven that it will save money/earn money, it will be appealing for the hospital.  
 
Culturally speaking 
Old surgeons have their routine don’t want to change their method à not receptive 
Young surgeons à Receptive, have long term vision, keen to learn new tech and more interested 
Question of generation change, time and acceptation 
 
Future scenarios 
In 10 years, everybody will benefit from 3D plaster at the emergency. The technology will make it able 
to print a splint in 15-30min à Test phase right now 
Right now, 3D splints and prosthesis are still a test phase however looking at the barriers of today it is 




C. Doctor Thomas Schubert – Orthopedic surgeon, University Hospital of Saint Luc – Brussels, Belgium 
(18/11/2019) 
3D orthosis and prosthesis are in a translation phase, it is interesting to evaluate the right parameters to 
demonstrate if it can be commercialized. Every tech has a path: it goes from testing to being widely used 
if successful. 3D printing in the medical industry has huge potential (already in use or in translation or 
in test phase)  
Barriers and limitations 
Must be careful that the therapeutic effect is the same. Regarding the doctor the plaster, still more 
stability than 3D orthosis (must be proven that it has the same recovery impact and not deleterious). the 
precision comparing to a plaster is not advance enough. How to demonstrate that every splint or 
prosthesis are secure enough as there are all different à How to be sure that there are no conception 
errors. (Security of the patient). Comparing to trad ones they underwent testing 
Traditional ones: instantaneous service on the patient still not the case with 3D printed orthoses  
Replace a standard and well established treatment of plaster that works well 
Patient must be compliant  
 
Advantages and Opportunities 
Use other aspect of the 3D printing to create advantage. Use the material as a force to create a real 
advantage for the comfort of the patient but also for therapeutic impact.  
à Bi or tri material can be combined together to create articulated orthosis (flexibility at some place 
and immobility at others) 
à Resorbable material: Eg 1: the patient can leave it out the orthosis by itself when the treatment is 
done by immersing it in water : PVA filament. Eg 2: Make the scaffolding of the 3D product resorbable, 
immerse the product when 3D printed to leave out the scaffolding by itself. 
Added value on the comfort: proven: aerated parameter is also link to medical treatment (eg: a kid 
playing on the beach the sand can enter and leave out the orthoses) 
Recyclable: It can be systematized easily because the patient usually have to consult the doctor at the 
end of the treatment where the orthosis can be given back to be recyclable. 
 
Economically speaking 
INAMI set the prices of the orthoses and prostheses 
Part of the price is paid by the patient, the other by the health insurance to the orthotist. Orthopedic 
surgeons make money on the patient consultations.  
 
SaaS & End to End solution 
End to end the refund of the orthosis or prosthesis goes to the manufacturer, barrier of adoption for the 
orthotist who does not make money anymore.  
With SaaS, the refund is still going to the orthotist and the manufacturer ask a small percentage of it. 




Orthopedic surgeons are interested by 3D printing because they work through 3D everyday through 3D 
surgery. Generally speaking, only a niche of the doctors find it interesting. 
 
Future scenarios 
Must demonstrate that medically no deleterious and financially speaking it has advantage over the 
traditional orthoses and prostheses. 
1. link together comfort (already proven that it is better) and therapeutic (must be proven similar 
or advantages) impact link together  
2. Link together time (must proof it saves time) and finance (cost of the product for 3D printers, 
education and maintenance)  
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à If both categories are proven to be beneficial over the traditional ones then don’t see why it shouldn’t 
be commercialized. It has a future 
Exponential curve of the tech must be careful of the fast expansion  
 
On long term, 3D printing manufacturer cannot stay alive just through modelization of complex cases 
(because too few to earn money just through those, comparing to standard model) 
Comparing with the led à The evolution of the tech, nobody believed that the led could replace the 
bulb of Thomas Edisson because the bulb worked perfectly why should we need something different? 
When it has been realized that the LED could light enough/similar comparing to bulb and was saving 

































D. Doctor Robert Elbaum – Orthopedic surgeon, president of the orthopedic surgeons committee at 
CHIREC Hospital- Brussels, Belgium (19/11/2019) 
 
Kids are more keen to get fracture link to their way of living and wear a cast. An environment where 
the kids are more subject to fall down etc. Small fracture that is one of the fracture most common à 
Huge market for the 3D. Two to four weeks of recovery. Focus on orthoses in the pediatric 
department. 
Ideal in post trauma for 3D device: the few days following the injured limb because in emergency more 
favorable to put pre-fabricated immobilization orthosis that let the limb breath. 
Every device system must go through an orthotist 
Would be ideal to have a 3D printer in the office  
Contact Pascal Rase – Orthopedia firm – corps enseignant  
Contact Nathalie Geerts – Ortheis 
 
Ent to end: the manufacturer gets the refund but has an agreement with the orthotist because the 
manufacturer does not have the right to medically treat the patient. Then the 3D orthosis will be placed 
by the orthotist. 
What would be the best scenario regarding the organizational process: orthotist have inhouse 3D printers 
and are educated to do the scan and modelization, pay a fee to the 3D printing manufacturers to benefit 
from the software scan and modelization. Interesting to produce on site.  
Reimburse from the health insurance to the orthotist: 100% refund.   
Prospective studies to proof the therapeutic impact: necessary. The results of the study at Chirec are not 
out yet. Ask the article and see if it can be included in the dissertation. Mentioned: Submitted for 
publication (first articles that mention the first studies and the results). 
Comfort is link to medical and therapeutic impact. Because comfort have an impact on the treatment 
and the resilience of the treatment. If the patient does not approve the orthoses or it is too uncomfortable, 
bigger chance that the patient will not wear it as he should. Waterproof is not only about comfort but 
medical too. Example a cast that does not resist to water à Loose the medical efficacy  
The surgeon gets the money of the act of immobilization and the consultation à in emergency a cast is 
needed on the moment. No financial gain from the orthopedic devices. 
On the long term: interesting for the INAMI to establish 3D codes 
SaaS: required a tariff code for in house 3D printing for the surgeons. However, the surgeons prefer to 
work in collaboration with the orthotist because no time to produce in house 3D devices. Asking them 
additional work.  
Important customization for complex case: not proven to have an optimal system at the immobilization 
level. Limited factor: bring sufficient correction during the modelization phase. 
Disadvantage: The precision of the orthoses and the closing system. Not yet in the commercialization 
phase. It must be totally adapted to the cutaneous surface, shape, morphology. The cast can do it but 
with the secondary inconvenient à Bigger risk of infections.  
In the near future: Will take a prominent place if the facility are in house. 
3D manufacturer must get the exclusivity and patent their products and work in the synergy with the 
orthotist and orthopedic surgeons.  
 59 
E. Louis-Philippe Broze - CEO of Spentys - Brussels, Belgium (21/11/2019) 
Actual business model “end to end” is suitable for small group of orthotists because they do not produce 
themselves the orthoses and prostheses. However, the main target is bigger group of orthotists.  
Small orthotists represent 40% of the market.  
 
Why the orthotists are favorable to 3D:  
1. Gain in operational flexibility 
2. Decrease the price and then increase their margins (no need for a physical person to produce the 
devices, gain in time) à Cost of production on the long term is cheaper. The investment cost is 
important the fixed cost decreases. 
Development of Spentys for 2020 – 2 axes 
Chronic axis: for complex cases 
Also divided in two axes. 1st one production is done at Spentys (Good way to convince to use the 
technology, gain in visibility and then introduce the SaaS model) 
2nd one: give the solution / SaaS where the hospitals have 3D printer facility. No leasing offers, hospitals 
pay a fee for the materials, platform, Software of 3D modeling, Software of certification.  
The  
Traumatic axis. Construction of the business case with 5 pilot cases by printing cast in less than 2 hours. 
The materials used are resin that solidified with light. DLP method with the Atum3D printers. Resin is 
costly. 
Business model: leasing of the 3D printers (2) in hospitals. Hospitals pay a monthly fee for the entire 
packages. 
Actual pricing situation: Don’t know yet the pricing. Know it’s gonna be a monthly fee + a variable fee 
regarding the amount of orthoses made per month. (look at the refund code and decide on the percentage 
of it) 
 
Personal conviction: The 3D orthoses represent a gain of comfort and quality of life. Spentys is entering 
a scientific procedure to proof this conviction. Otherwise they don’t have any credibility. à Clinical 
studies are in progress to proof first the non-inferiority comparing to traditional orthoses. The long term 
objective is to proof the superiority.  
Clinical studies in progress in Bâle, in the Netherlands, in Belgium (In 5 different hospitals). 
 
Spentys in the future is not just orthosis prosthesis and cast, the objective is to become a platform to do 
many different customizable thing (implants, organs, cutting guide). Enable a mass customization of 
orthopedic devices and other medical devices.  
 
The comfort is link to the medical impact.  
Why is it more aesthetics: more organic, lighter, more aerated, more beautiful.  
Disadvantage: Time of production first major one for the post traumatic axis. Error of printers. 
Reliability of the scan.  
Disrupt the way of working of the medical core. à Which generate resistance to change. 
 
Competitors: analysis documents 
Actual pricing: INAMI code is 100% refund by the health insurance, the orthotist can additionally ask 
(overcharge) a user fee of at most 10% of the INAMI code that must be paid by the patient and is not 
refund. 
 
Estimation: how long is it to produce a traditional forearm orthosis. Not done the calculation yet 
 
Play on the fact that material can bring a real advantage: resorbable or pluri-material. Find new 
characteristic to the device to sell it. Start already working on the flexi material, also play on the structure 
to gain in flexibility.  
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F. Non mentioned – employee at INAMI – responsible for orthoses and prostheses – Brussels, Belgium 
(06/12/2019) 
 
The health minister has an annual budget for the public health. She/He decides the amount for 
orthopedic immobilizer devices. The INAMI set the refund codes on the basis of those budgets. 
The main role of the INAMI is to be the mediator between the different stakeholder involved. 
They are supposed to be neutral.  
They gather the stakeholder around a table and through the consultation look at the different 
parameters and decide to agree on new regulation or not.  
For the orthopedic industry the stakeholders involved are: 
1. Patient  
2. Service provider - Orthotist and Orthopedic surgeon 
3. Health Insurance – Mutuel  
4. Public Health representative 
5. Device supplier/manufacturer 
 
Regarding the 3D printing technology: for the moment there is no specific codes for 3D printed 
orthoses or prostheses. The devices are categorized between “Pre-fabriqué” = “Pre-made” and 
“sur-mesure” = “made to mesure”  
à The 3D orthoses and prostheses find themsleves in those two categories. It means that it can 
already be commercialized if the devices got the EU certification regarding the biocompatibility 
and are aligned with the INAMI nomenclature. It is then not a barrier for the diffusion of the 
tech on the Belgian market.  
 
The 3D tech in the orthopedic industry can be compare with the hearing aids 
 
The European Union set medical requirements in terms of 3D materials in order to have a 
traceability of the product. This can be a barrier of diffusion or the decrease the amount of 
manufacturer on the market. Hard to get the certification 
 
Possibility to contact the organisme professionnel: union professionnel belge des technologies  
orthopedic: 022517578 
Thomas Moor 
 
 
